دورية أكاديمية

Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions

التفاصيل البيبلوغرافية
العنوان: Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions
المؤلفون: Guvenal, Tevfik, Durna, Aysenur, Erden, Omur, Guvenal, Feray, Cetin, Meral, Cetin, Ali
المساهمون: Guvenal, Tevfik Celal Bayar Univ, Fac Med, Kadin Hastaliklari & Dogum Anabilim Dali, Dept Obstet & Gynecol, Manisa, Turkey -- Durna, Aysenur Anadolu Hosp, Dept Neurol, Antalya, Turkey -- Erden, Omur Sivas State Hosp, Dept Obstet & Gynecol, Sivas, Turkey -- Guvenal, Feray Buca Med Ctr, Dept Obstet & Gynecol, Izmir, Turkey -- Cetin, Meral -- Cetin, Ali Cumhuriyet Univ, Fac Med, Dept Obstet & Gynecol, Sivas, Turkey, Cetin, Ali -- 0000-0002-5767-7894
بيانات النشر: SPRINGER
سنة النشر: 2009
المجموعة: Sivas Cumhuriyet University Institutional Repository
مصطلحات موضوعية: cerebral blood flow, cognitive function, conjugated equine estrogens, medroxyprogesterone acetate, postmenopausal hormone therapy, raloxifene, tibolone
الوصف: WOS: 000270154900007 ; PubMed ID: 19672567 ; The purpose of this study was to compare the effects of different postmenopausal hormone therapy regimens, namely conjugated equine estrogens (CEE), CEE plus medroxyprogesterone acetate (MPA), tibolone, and raloxifene on cerebral blood flow and cognitive functions. A total of 64 healthy postmenopausal women admitted to the Department of Obstetrics and Gynecology, Cumhuriyet University, Turkey were included in this study. Patients were divided into five groups with respect to the treatment protocols: CEE 0.625 mg/day (n=13); CEE 0.625 mg/day + MPA 2.5 mg/day (n=14); tibolone 2.5 mg/day (n=11); raloxifene 60 mg/day (n=9); and control (n=17). The CEE group included only women with surgical menopause. Those who were on hormonal therapy, who had previously used hormonal therapy, who had neurological disorders, or who did not accept the longterm follow-up were excluded from the study. Demographic and clinic characteristics were recorded. Before starting the therapy regimens, cerebral blood flow was evaluated by internal carotid artery and middle cerebral artery peak systolic velocity, and pulsatility index measurements via Doppler ultrasonography. Cognitive functions were evaluated by the Standardized Mini-Mental Test. The mean follow-up period was 10.9 +/- 2.4 months, ranging between 8 and 16 months. After the follow-up period, the cerebral blood flow, and cognitive function of each woman was re-evaluated. Demographic and clinical characteristics of the women were not significantly different between the study groups (P > 0.05). There were no significant differences between the pretreatment and posttreatment values for cerebral blood flow indices and cognitive function scores in any of the study groups (P > 0.05). Different postmenopausal hormone therapy regimens have not revealed any significant effects on either cerebral blood flow or cognitive function.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0741-238X
العلاقة: ADVANCES IN THERAPY; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://dx.doi.org/10.1007/s12325-009-0058-xTest; https://hdl.handle.net/20.500.12418/10081Test; 26; 811; 805
DOI: 10.1007/s12325-009-0058-x
الإتاحة: https://doi.org/20.500.12418/10081Test
https://doi.org/10.1007/s12325-009-0058-xTest
https://hdl.handle.net/20.500.12418/10081Test
حقوق: info:eu-repo/semantics/closedAccess
رقم الانضمام: edsbas.2A809A52
قاعدة البيانات: BASE
الوصف
تدمد:0741238X
DOI:10.1007/s12325-009-0058-x